Amlodipine/Candesartan/D-086

N/A

Report date: 2022/03/08 16:46:53

Base Information

Drug NameAmlodipine/Candesartan/D-086

Drug Alias NameD-086+Amlodipine+Candesartancandesartan/amlodipine/D-086candesartan + amlodipine + D-086Amlodipine/D-086/CandesartanAmlodipine+Candesartan+D-086 +[6]

ClassificationSmall molecules

Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers

TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel

Therapy Area/IndicationsHyperlipidemiasHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Candesartan Cilexetil Amlodipine Besylate D-086

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesChong Kun Dang Pharmaceutical Corp

China Registration ClassN/A

Develop Information

Active CompaniesChong Kun Dang Pharmaceutical Corp

Inactive CompaniesN/A

Active IndicationsHyperlipidemiasHypertension

Inactive IndicationsN/A

Other Information

ATC CodeN/A